Stem cell therapy is part of a rapidly advancing field of regenerative medicine focused on harnessing the body’s natural ability to repair, replace, and restore damaged tissues. Ongoing research continues to explore how stem cells may support recovery, reduce inflammation, and promote healing across a wide range of orthopedic, neurological, and chronic health conditions.

More About the Science of Stem Cells

Mesenchymal Stem Cells and Exosomes in Ischemic Brain Injury

This NIH National Library of Medicine article reviews emerging research on the use of mesenchymal stem cells (MSCs) and their exosomes as potential therapies for ischemic stroke. The authors explain how these regenerative therapies may help repair damaged brain tissue by promoting nerve and blood vessel regeneration, reducing inflammation, and supporting the brain’s natural recovery process after stroke.

The review also highlights that while laboratory and preclinical studies show promising results, additional research is still needed to address challenges such as treatment standardization, dosage, delivery methods, and long-term safety before these therapies can become widely adopted in clinical practice.

Unlocking the Therapeutic Potential of Exosomes Derived From Nasal Olfactory Mucosal Mesenchymal Stem Cells: Restoring Synaptic Plasticity, Neurogenesis, and Neuroinflammation in Schizophrenia

This NIH National Library of Medicine article explores an experimental approach to treating schizophrenia using stem cell–derived exosomes. Researchers hypothesize that exosomes obtained from olfactory mucosal mesenchymal stem cells and delivered intranasally may help reduce schizophrenia-like symptoms, including behavioral and cognitive impairments associated with the disorder. The study highlights the growing interest in regenerative and cell-signaling therapies as potential future treatments for complex neurological and psychiatric conditions where traditional therapies may have limitations.

Intranasal Administration of Stem Cell-Derived Exosomes for Central Nervous System Diseases

This NIH National Library of Medicine article reviews the growing potential of stem cell–derived exosomes as a treatment for central nervous system disorders. Exosomes are tiny vesicles released by cells that carry proteins, RNA, and other signaling molecules capable of influencing healing and communication between cells. Researchers highlight their therapeutic benefits, including reducing inflammation, protecting nerve cells, supporting new blood vessel and nerve growth, and potentially delivering targeted drugs to damaged brain tissue.

This review also focuses on intranasal delivery as a promising non-invasive method for administering exosomes directly to the brain. By utilizing pathways connected to the olfactory and trigeminal nerves, intranasal therapy may help bypass the blood-brain barrier and improve treatment effectiveness for neurological conditions. Finally, it summarizes current research, therapeutic mechanisms, and future clinical potential of this emerging regenerative medicine approach.

Intranasal Administration of Stem Cell-Derived Exosome Alleviates Cognitive Impairment Against Subarachnoid Hemorrhage

This study discussed in this NIH National Library of Medicine article investigates whether exosomes derived from mesenchymal stem cells (MSCs) could help reduce brain damage after subarachnoid hemorrhage (SAH), a severe type of bleeding in the brain that currently has limited treatment options. Researchers delivered the exosomes intranasally and found that the therapy improved cognitive function, reduced inflammation and cell death, protected the blood-brain barrier, and increased neuronal survival.

Imaging studies showed that the exosomes successfully reached multiple regions of the brain through nasal delivery pathways, including the olfactory and trigeminal nerves. The findings suggest that intranasal MSC-derived exosome therapy may represent a promising non-invasive regenerative treatment approach for neurological injury and brain hemorrhage.

Intranasal Administration of Mesenchymal Stem Cell-Derived Exosome Alleviates Hypoxic-Ischemic Brain Injury

This study in this NIH National Library of Medicine article examines the use of mesenchymal stem cell–derived exosomes as a potential treatment for hypoxic-ischemic brain injury, a serious condition caused by reduced oxygen supply to the brain that commonly occurs after cardiac arrest. Researchers administered exosomes intranasally and found that the treatment improved long-term cognitive function, reduced neuronal cell death, and increased survival of brain cells in areas associated with memory and learning.

The study also demonstrated that intranasally delivered exosomes successfully reached key brain regions through olfactory pathways and were absorbed by microglia, where they helped reduce harmful inflammatory responses. These findings suggest that intranasal exosome therapy may offer a promising non-invasive regenerative strategy for treating brain injury caused by oxygen deprivation.

Scientists Reverse Brain Aging, With a Nasal Spray

This article highlights groundbreaking research from Texas A&M University exploring a nasal spray designed to combat brain aging and cognitive decline associated with inflammation, often referred to as “brain fog.” The study found that just two doses of the spray significantly reduced inflammation in the brain, improved cellular energy function, and enhanced memory performance.

Led by researchers in regenerative medicine, the work suggests that non-invasive intranasal therapies may offer a promising future approach for reversing aspects of age-related neurological decline and restoring healthier brain function.

start your journey

Our compassionate team is here to listen, guide, and support you every step of the way. Whether you’re seeking relief from a chronic condition, exploring innovative therapies, or simply looking to feel your best again, we’re ready to help.

payment information

Please contact us directly for payment instructions and additional information at (915) 348-5900

COMING SOON!

We look forward to offering this service very soon! 

Check back with us…